The global dry eye treatment devices market size is estimated to reach USD 400.8 million by 2027, expanding at a CAGR of 6.4%, according to a new report by Grand View Research, Inc. The increasing demand for targeted, non-invasive, faster, and patient compliant treatment methods to alleviate dry eye symptoms are the factors expected to drive the market during the forecast period.
The rising incidence of causative risk factors such as over usage of contact lenses, prolonged exposure to digital screens, diabetes, glaucoma, and Sjogren's syndrome globally is anticipated to propel market growth. For instance, the Americans are estimated to spend an average time of more than 10.0 hours a day at visual display terminals.
The increasing number of clinical and research activities conducted to evaluate the safety and efficacy of advanced dry eye treatment devices such as IPL and BBL will boost the growth of the market. As the application of these advanced technologies in eye care is at a nascent stage in many countries, thereby clinical evidence is essential to increase provider confidence over its acceptance. Besides, clinical studies of these technologies are showing promising results in comparison with conventional methods to treat dry eye syndrome.
The availability of alternative treatment, high cost of IPL/BBL treatment, numerous contraindications associated with IPL, and lack of an efficient health insurance policy in several countries are the factors rendering the growth of the market. For instance, the treatment of dry eye syndrome using IPL is not covered under the NHS, a major provider of healthcare service in the U.K.
Request a free sample copy or view report summary: Dry Eye Treatment Devices Market Report
The Meibomian Gland Expression (MGX) technology held the largest market share in 2019 owing to the factors such as frequent product launches, cost-effectiveness, and improving accessibility
IPL and Combination (IPL+MGX) technologies are expected to grow at the fastest rate during the forecast period due to the factors such as the development of economical and compact-sized IPL devices having versatility in treating skin tone of all types
In Asia Pacific, the market is expected to grow at the fastest rate of 6.9% during the forecast period
North America held the largest market share in 2019 and is anticipated to maintain its dominance over the forecast period
This is attributable to the growing prevalence of dry eye disease, increasing R&D expenditure, and many ophthalmology trade conferences and expos conducted in the U.S. and Canada.
Grand View Research has segmented the global dry eye treatment devices market on the basis of technology and region:
Broadband light (BBL)
Intense Pulsed Light (IPL)
Meibomian Gland Expression (MGX)
Dry Eye Treatment Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)
Middle East & Africa
List of Key Players of Dry Eye Treatment Devices Market
MiBo Medical Group
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."